Development of a CRISPR-Cas9 system for efficient genome editing of Candida lusitaniae

mSphere

Volumn 2, Issue 3, 2017, Pages

  Norton, Emily L ^a   Sherwood, Racquel K ^a   Bennett, Richard J ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

CRISPR; DNA double strand break; Homology directed repair; Nonhomologous end joining

Indexed keywords

EID: 85027434900     PISSN: None     EISSN: 23795042     Source Type: Journal    
DOI: 10.1128/mSphere.00217-17     Document Type: Article

References (35)

1. Butler G, Rasmussen MD, Lin MF, Santos MA, Sakthikumar S, Munro CA, Rheinbay E, Grabherr M, Forche A, Reedy JL, Agrafioti I, Arnaud MB, Bates S, Brown AJ, Brunke S, Costanzo MC, Fitzpatrick DA, de Groot PW, Harris D, Hoyer LL, Hube B, Klis FM, Kodira C, Lennard N, Logue ME, Martin R, Neiman AM, Nikolaou E, Quail MA, Quinn J, Santos MC, Schmitzberger FF, Sherlock G, Shah P, Silverstein KA, Skrzypek MS, Soll D, Staggs R, Stansfield I, Stumpf MP, Sudbery PE, Srikantha T, Zeng Q, Berman J, Berriman M, Heitman J, Gow NA, Lorenz MC, Birren BW, Kellis M. 2009. Evolution of pathogenicity and sexual reproduction in eight Candida genomes. Nature 459:657-662. https://doi.org/10.1038/nature08064
2. Giri S, Kindo AJ. 2012. A review of Candida species causing blood stream infection. Indian J Med Microbiol 30:270-278. https://doi.org/10.4103/ 0255-0857.99484
3. Breuer U, Harms H. 2006. Debaryomyces hansenii-an extremophilic yeast with biotechnological potential. Yeast 23:415-437. https://doi.org/ 10.1002/yea.1374
4. Blinkhorn RJ, Adelstein D, Spagnuolo PJ. 1989. Emergence of a new opportunistic pathogen, Candida lusitaniae. J Clin Microbiol 27:236-240
5. Minari A, Hachem R, Raad I. 2001. Candida lusitaniae: a cause of breakthrough fungemia in cancer patients. Clin Infect Dis 32:186-190. https:// doi.org/10.1086/318473
6. Hawkins JL, Baddour LM. 2003. Candida lusitaniae infections in the era of fluconazole availability. Clin Infect Dis 36:e14-e18. https://doi.org/10 .1086/344651
7. Atkinson BJ, Lewis RE, Kontoyiannis DP. 2008. Candida lusitaniae fungemia in cancer patients: risk factors for amphotericin B failure and outcome. Med Mycol 46:541-546. https://doi.org/10.1080/136937 80801968571
8. Strati F, Di Paola M, Stefanini I, Albanese D, Rizzetto L, Lionetti P, Calabrò A, Jousson O, Donati C, Cavalieri D, De Filippo C. 2016. Age and gender affect the composition of fungal population of the human gastrointestinal tract. Front Microbiol 7:1227. https://doi.org/10.3389/fmicb.2016 .01227
9. Christenson JC, Guruswamy A, Mukwaya G, Rettig PJ. 1987. Candida lusitaniae: an emerging human pathogen. Pediatr Infect Dis J 6:755-757. https://doi.org/10.1097/00006454-198708000-00013
10. Papon N, Courdavault V, Clastre M, Bennett RJ. 2013. Emerging and emerged pathogenic Candida species: beyond the Candida albicans paradigm. PLoS Pathog 9:e1003550. https://doi.org/10.1371/journal .ppat.1003550
11. Asner SA, Giulieri S, Diezi M, Marchetti O, Sanglard D. 2015. Acquired multidrug antifungal resistance in Candida lusitaniae during therapy. Antimicrob Agents Chemother 59:7715-7722. https://doi.org/10.1128/ AAC.02204-15
12. Hogan DA, Willger SD, Dolben EL, Hampton TH, Stanton BA, Morrison HG, Sogin ML, Czum J, Ashare A. 2016. Analysis of lung microbiota in bronchoalveolar lavage, protected brush and sputum samples from subjects with mild-to-moderate cystic fibrosis lung disease. PLoS One 11:e0149998. https://doi.org/10.1371/journal.pone.0149998
13. Centers for Disease Control and Prevention 2016. Global emergence of invasive infections caused by the multidrug-resistant yeast Candida auris. Centers for Disease Control and Prevention, Atlanta, GA. https:// www.cdc.gov/fungal/diseases/candidiasis/candida-auris-alert.html
14. Larkin E, Hager C, Chandra J, Mukherjee PK, Retuerto M, Salem I, Long L, Isham N, Kovanda L, Borroto-Esoda K, Wring S, Angulo D, Ghannoum M. 2017. The emerging pathogen Candida auris: growth phenotype, virulence factors, activity of antifungals, and effect of SCY-078, a novel glucan synthesis inhibitor, on growth morphology and biofilm formation. Antimicrob Agents Chemother 61:e02396-16. https://doi.org/10 .1128/AAC.02396-16
15. Butler G. 2010. Fungal sex and pathogenesis. Clin Microbiol Rev 23: 140-159. https://doi.org/10.1128/CMR.00053-09
16. Ene IV, Bennett RJ. 2014. The cryptic sexual strategies of human fungal pathogens. Nat Rev Microbiol 12:239-251. https://doi.org/10.1038/ nrmicro3236
17. Lee SC, Ni M, Li W, Shertz C, Heitman J. 2010. The evolution of sex: a perspective from the fungal kingdom. Microbiol Mol Biol Rev 74: 298-340. https://doi.org/10.1128/MMBR.00005-10
18. Reedy JL, Floyd AM, Heitman J. 2009. Mechanistic plasticity of sexual reproduction and meiosis in the Candida pathogenic species complex. Curr Biol 19:891-899. https://doi.org/10.1016/j.cub.2009.04.058
19. Lam I, Keeney S. 2014. Mechanism and regulation of meiotic recombination initiation. Cold Spring Harb Perspect Biol 7:a016634. https://doi .org/10.1101/cshperspect.a016634
20. Bloomfield G. 2016. Atypical ploidy cycles, Spo11, and the evolution of meiosis. Semin Cell Dev Biol 54:158-164. https://doi.org/10.1016/j .semcdb.2016.01.026
21. Sherwood RK, Scaduto CM, Torres SE, Bennett RJ. 2014. Convergent evolution of a fused sexual cycle promotes the haploid lifestyle. Nature 506:387-390. https://doi.org/10.1038/nature12891
22. Doudna JA, Charpentier E. 2014. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science 346:1258096. https:// doi.org/10.1126/science.1258096
23. Vyas VK, Barrasa MI, Fink GR. 2015. A Candida albicans CRISPR system permits genetic engineering of essential genes and gene families. Sci Adv 1:e1500248. https://doi.org/10.1126/sciadv.1500248
24. Min K, Ichikawa Y, Woolford CA, Mitchell AP. 2016. Candida albicans gene deletion with a transient CRISPR-Cas9 system. mSphere 1:e00130-16. https://doi.org/10.1128/mSphere.00130-16
25. Ng H, Dean N. 2017. Dramatic improvement of CRISPR/Cas9 editing in Candida albicans by increased single guide RNA expression. mSphere 2:e00385-16. https://doi.org/10.1128/mSphere.00385-16
26. Reuss O, Vik A, Kolter R, Morschhäuser J. 2004. The SAT1 flipper, an optimized tool for gene disruption in Candida albicans. Gene 341: 119-127. https://doi.org/10.1016/j.gene.2004.06.021
27. Chiruvella KK, Liang Z, Wilson TE. 2013. Repair of double-strand breaks by end joining. Cold Spring Harb Perspect Biol 5:a012757. https://doi .org/10.1101/cshperspect.a012757
28. Hsu PD, Lander ES, Zhang F. 2014. Development and applications of CRISPR-Cas9 for genome engineering. Cell 157:1262-1278. https://doi .org/10.1016/j.cell.2014.05.010
29. Dudásová Z, Dudás A, Chovanec M. 2004. Non-homologous end-joining factors of Saccharomyces cerevisiae. FEMS Microbiol Rev 28:581-601. https://doi.org/10.1016/j.femsre.2004.06.001
30. Fell VL, Schild-Poulter C. 2015. The Ku heterodimer: function in DNA repair and beyond. Mutat Res Rev Mutat Res 763:15-29. https://doi.org/ 10.1016/j.mrrev.2014.06.002
31. Krappmann S. 2007. Gene targeting in filamentous fungi: the benefits of impaired repair. Fungal Biol Rev 21:25-29. https://doi.org/10.1016/j.fbr .2007.02.004
32. Foureau E, Courdavault V, Rojas LF, Dutilleul C, Simkin AJ, Crèche J, Atehortùa L, Giglioli-Guivarc'h N, Clastre M, Papon N. 2013. Efficient gene targeting in a Candida guilliermondii non-homologous end-joining pathway-deficient strain. Biotechnol Lett 35:1035-1043. https://doi.org/ 10.1007/s10529-013-1169-7
33. Nayak T, Szewczyk E, Oakley CE, Osmani A, Ukil L, Murray SL, Hynes MJ, Osmani SA, Oakley BR. 2006. A versatile and efficient gene-targeting system for Aspergillus nidulans. Genetics 172:1557-1566. https://doi.org/ 10.1534/genetics.105.052563
34. Grahl N, Demers EG, Crocker AW, Hogan DA. 2017. Use of RNA-protein complexes for genome editing in non-albicans Candida species. mSphere 2:e00218-17. https://doi.org/10.1128/mSphere.00218-17
35. Skrzypek MS, Binkley J, Binkley G, Miyasato SR, Simison M, Sherlock G. 2017. The Candida Genome Database (CGD): incorporation of Assembly 22, systematic identifiers and visualization of high throughput sequencing data. Nucleic Acids Res 45:D592-D596. https://doi.org/10.1093/nar/ gkw924